Role of an ornithine rhamnolipid pigment in GBS virulence
Role of an ornithine rhamnolipid pigment in GBS virulence
批准号:
8745832
负责人:
Lakshmi Rajagopal
金额:
$45.83万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2019-06-30
关键词:
AffectAgeAntibiotic ProphylaxisAntibodiesBacillus cereusBacterial InfectionsBiochemicalBiologicalBrainBurkholderia pseudomalleiCell DegranulationCellsCerebral PalsyClinicalCommunicable DiseasesCytolysisDataDiseaseEndothelial CellsEnvironmentEpithelial CellsErythrocytesEukaryotic CellFutureGenerationsGenesGenital systemGram-Positive BacteriaHumanImmune responseInfantInfectionInflammatory ResponseInterleukin-1Lipid BilayersLipidsLow Birth Weight InfantLungMeasuresMediatingMediator of activation proteinMembraneMeningitisMental RetardationMolecularMorbidity - disease rateMusNeurologicNewborn InfantOrganismOrnithinePathogenesisPenetrationPerinatalPeritonealPigmentsPlacentaPneumoniaPremature BirthPremature LaborPrevention strategyProteinsPseudomonas aeruginosaPublic HealthReactive Oxygen SpeciesReportingRoleSeizuresSepsisStreptococcal InfectionsStreptococcus Group BStreptococcus pneumoniaeTNF geneTissuesToxinTransgenic OrganismsUterine ContractionVaginaVirulenceVirulence FactorsWomanWorkamniotic cavityanalogbasechemical synthesiscytokinecytotoxicearly onsethuman mortalityin uteroinsightintrapartumlate disease onsetmacrophagemast cellmortalitynovelpathogenpreventpublic health relevanceresponserhamnolipidstillbirththerapeutic developmentvaginal fluid
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Morbidity and mortality of human newborns remain significant public health concerns. Streptococcus agalactiae or Group B Streptococcus (GBS) cause invasive infections such as pneumonia, sepsis and meningitis in human newborns. Moreover, GBS are a significant cause of in utero infections leading to preterm births and stillbirths. We recently showed that the pluripotent toxin important for GBS infections is an ornithine rhamnolipid pigment also known as granadaene. The pigment/lipid toxin is cytotoxic to a number of host cells and induces a proinflammatory immune response. The objective of this proposal is to understand how the pigment causes host cell lysis and induces an immune response and to also define how pigment mediated activation of host cells affects GBS colonization and infection-associated preterm births.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neutralizing the GBS hemolytic lipid toxin
-
批准号:10392131
-
项目类别:
-
资助金额:$80.59万
-
财政年份:2022
-
负责人:Lakshmi Rajagopal
-
依托单位:
Neutralizing the GBS hemolytic lipid toxin
-
批准号:10647649
-
项目类别:
-
资助金额:$82.33万
-
财政年份:2022
-
负责人:Lakshmi Rajagopal
-
依托单位:
Role of human cervical mucus plugs in ascending GBS infection
-
批准号:9303886
-
项目类别:
-
资助金额:$23.37万
-
财政年份:2016
-
负责人:Lakshmi Rajagopal
-
依托单位:
Role of human cervical mucus plugs in ascending GBS infection
-
批准号:9165076
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2016
-
负责人:Lakshmi Rajagopal
-
依托单位:
Role of an ornithine rhamnolipid pigment in GBS virulence
-
批准号:9097532
-
项目类别:
-
资助金额:$49.12万
-
财政年份:2014
-
负责人:Lakshmi Rajagopal
-
依托单位:
Environmental Signals that regulate GBS virulence
-
批准号:8619390
-
项目类别:
-
资助金额:$30.46万
-
财政年份:2013
-
负责人:Lakshmi Rajagopal
-
依托单位:
Eukaryotic-type signaling mediates two-component regulation of GBS virulence
-
批准号:8064334
-
项目类别:
-
资助金额:$39.37万
-
财政年份:2007
-
负责人:Lakshmi Rajagopal
-
依托单位:
Eukaryotic-type signaling mediates two-component regulation of GBS virulence
-
批准号:7252733
-
项目类别:
-
资助金额:$39.64万
-
财政年份:2007
-
负责人:Lakshmi Rajagopal
-
依托单位:
Eukaryotic-type signaling mediates two-component regulation of GBS virulence
-
批准号:7805615
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2007
-
负责人:Lakshmi Rajagopal
-
依托单位:
Eukaryotic-type signaling mediates two-component regulation of GBS virulence
-
批准号:7413653
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2007
-
负责人:Lakshmi Rajagopal
-
依托单位:
Eukaryotic-type signaling mediates two-component regulation of GBS virulence
-
批准号:7618477
-
项目类别:
-
资助金额:$40.76万
-
财政年份:2007
-
负责人:Lakshmi Rajagopal
-
依托单位:
Eukaryotic-signaling mediates two-component regulation of GBS virulence
-
批准号:8663520
-
项目类别:
-
资助金额:$48.24万
-
财政年份:2006
-
负责人:Lakshmi Rajagopal
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: